BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 31789821)

  • 1. EBV-Positive Primary Large B-Cell Lymphoma: The Role of Immunohistochemistry and XPO1 in the Diagnosis of Mediastinal Lymphomas.
    Maracaja DLV; Puthenpura V; Pels SG; O'Malley DP; Sklar JL; Finberg KE; Xu ML
    Appl Immunohistochem Mol Morphol; 2020; 28(10):725-730. PubMed ID: 31789821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
    Virchows Arch; 2023 Dec; 483(6):733-749. PubMed ID: 37530791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
    Caillot M; Miloudi H; Taly A; Profitós-Pelejà N; Santos JC; Ribeiro ML; Maitre E; Saule S; Roué G; Jardin F; Sola B
    Mol Oncol; 2023 Dec; 17(12):2546-2564. PubMed ID: 36727672
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Primary mediastinal large B-cell lymphoma in women: about five cases].
    Ouassou S; Herrak L; Achachi L; Nachite F; Znati K; Ftouh ME
    Pan Afr Med J; 2016; 24():181. PubMed ID: 27795778
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic Factors in Familial Manifestation of Primary Mediastinal Large B-Cell Lymphoma over Two Generations.
    Juskevicius D; Lundberg P; Tzankov A; Dirnhofer S; Stenner F
    Pathobiology; 2023; 90(6):422-428. PubMed ID: 37490879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Chinese expert consensus on the diagnosis and management of primary mediastinal large B-cell lymphoma (2024)].
    ;
    Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):209-214. PubMed ID: 38716591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EBV-Positive Intravascular Large B-Cell Lymphoma of the Small Intestine: A Case Report and Literature Review.
    Pan C; Ma X; Yao Y; Wang C
    Int J Surg Pathol; 2024 May; 32(3):586-593. PubMed ID: 37431259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ruxolitinib significantly enhances
    Lee S; Shah T; Yin C; Hochberg J; Ayello J; Morris E; van de Ven C; Cairo MS
    Oncotarget; 2018 Feb; 9(11):9776-9788. PubMed ID: 29515770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric Aggressive Mature B-Cell Lymphomas, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.
    Barth M; Xavier AC; Armenian S; Audino AN; Blazin L; Bloom D; Chung J; Davies K; Ding H; Ford JB; Galardy PJ; Hanna R; Hayashi R; Lee-Miller C; Machnitz AJ; Maloney KW; Marks L; Martin PL; McCall D; Pacheco M; Reilly AF; Roshal M; Song S; Weinstein J; Zarnegar-Lumley S; McMillian N; Schonfeld R; Sundar H
    J Natl Compr Canc Netw; 2022 Nov; 20(11):1267-1275. PubMed ID: 36351334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3247. PubMed ID: 38287530
    [No Abstract]   [Full Text] [Related]  

  • 11. Liposomal-encapsulated doxorubicin supercharge-containing front-line treatment improves response rates in primary mediastinal large B-cell lymphoma and mediastinal gray zone lymphoma.
    Picardi M; Giordano C; Pugliese N; Mascolo M; Varricchio S; Troncone G; Vigliar E; Bellavicine C; Lamagna M; Lisi D; Vincenzi A; Pane F
    Hematol Oncol; 2024 Jan; 42(1):e3242. PubMed ID: 38126215
    [No Abstract]   [Full Text] [Related]  

  • 12. Correction to: Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology.
    Gibson SE; Dojcinov S; Dotlic S; Hartmann S; Hsi ED; Klimkowska M; Melle F; Pileri SA; Ramsower CA; Rech K; Rimsza LM; Rodriguez-Pinilla SM; Tousseyn TA; de Jong D; Sabattini E
    Virchows Arch; 2023 Oct; ():. PubMed ID: 37828241
    [No Abstract]   [Full Text] [Related]  

  • 13. Mutational landscape of gray zone lymphoma.
    Sarkozy C; Hung SS; Chavez EA; Duns G; Takata K; Chong LC; Aoki T; Jiang A; Miyata-Takata T; Telenius A; Slack GW; Molina TJ; Ben-Neriah S; Farinha P; Dartigues P; Damotte D; Mottok A; Salles GA; Casasnovas RO; Savage KJ; Laurent C; Scott DW; Traverse-Glehen A; Steidl C
    Blood; 2021 Apr; 137(13):1765-1776. PubMed ID: 32961552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of DLBCL with a PMBL gene expression signature.
    Duns G; Viganò E; Ennishi D; Sarkozy C; Hung SS; Chavez E; Takata K; Rushton C; Jiang A; Ben-Neriah S; Woolcock BW; Slack GW; Hsi ED; Craig JW; Hilton LK; Shah SP; Farinha P; Mottok A; Gascoyne RD; Morin RD; Savage KJ; Scott DW; Steidl C
    Blood; 2021 Jul; 138(2):136-148. PubMed ID: 33684939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Composite and sequential lymphoma between classical Hodgkin lymphoma and primary mediastinal lymphoma/diffuse large B-cell lymphoma, a clinico-pathological series of 25 cases.
    Aussedat G; Traverse-Glehen A; Stamatoullas A; Molina T; Safar V; Laurent C; Michot JM; Hirsch P; Nicolas-Virelizier E; Lamure S; Regny C; Picquenot JM; Ledoux-Pilon A; Tas P; Chassagne-Clément C; Manson G; Lemal R; Fontaine J; Le Cann M; Salles G; Ghesquières H; Copie-Bergman C; Sarkozy C
    Br J Haematol; 2020 Apr; 189(2):244-256. PubMed ID: 32030731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Author Correction: The nuclear export protein XPO1 - from biology to targeted therapy.
    Azmi AS; Uddin MH; Mohammad RM
    Nat Rev Clin Oncol; 2021 Mar; 18(3):190. PubMed ID: 33235326
    [No Abstract]   [Full Text] [Related]  

  • 17. The nuclear export protein XPO1 - from biology to targeted therapy.
    Azmi AS; Uddin MH; Mohammad RM
    Nat Rev Clin Oncol; 2021 Mar; 18(3):152-169. PubMed ID: 33173198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. XPO1-dependent nuclear export as a target for cancer therapy.
    Azizian NG; Li Y
    J Hematol Oncol; 2020 Jun; 13(1):61. PubMed ID: 32487143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular Characterization of Primary Mediastinal Large B-Cell Lymphomas.
    Donzel M; Pesce F; Trecourt A; Groussel R; Bachy E; Ghesquières H; Fontaine J; Benzerdjeb N; Mauduit C; Traverse-Glehen A
    Cancers (Basel); 2023 Oct; 15(19):. PubMed ID: 37835560
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.